Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcio F Chedid

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|January 26, 2026
Mucosal Melanoma: Treatment Strategies for a Heterogeneous DiseaseJane Mattei, Marcio F Chedid
International Surgery|December 7, 2007
Mirizzi syndrome in a patient with anomalous connection of the cystic duct into the right hepatic ductMarcio F Chedid, Aljamir D Chedid
Melanoma Research|August 31, 2023
Mucosal melanoma: from molecular landscape to current treatment strategiesJane Mattei, Eduardo N Trindade, Marcio F Chedid
Annals of Hepatology|January 3, 2019
ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver TransplantationMarcio F Chedid, Rafael V Picon, Aljamir D Chedid
Nature Reviews. Nephrology|October 3, 2012
The role of complement in antibody-mediated rejection in kidney transplantationMark D Stegall, Marcio F Chedid, Lynn D Cornell
Current Pharmaceutical Design|March 16, 2026
Treatment Strategies for Hepatocellular Carcinoma: When Less is Not MoreGabriel Lazzarotto-da-Silva, Fabiane A Marek, Marcio F Chedid
Current Pharmaceutical Design|March 20, 2025
Surgical Excision Margins in Skin Melanomas with Breslow Thickness Greater than 2 Mm: A Systematic Review and Meta-AnalysisLucas S Floriano, Rafael V Picon, Camila Dagostim, et al.
Current Pharmaceutical Design|June 11, 2020
Immunosuppression in Liver Transplantation: State of the Art and Future PerspectivesGeir I Nedredal, Rafael V Picon, Marcio F Chedid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 29, 2014
Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donorsMarcio F Chedid, Charles B Rosen, Scott L Nyberg, et al.
Arquivos De Gastroenterologia|September 16, 2020
MELD EXCEPTION POINTS PROVIDE AN ENOURMOUS ADVANTAGE FOR RECEIVING A LIVER TRANSPLANT IN BRAZILSoraia Arruda, Marcio F Chedid, Michelle Moraes Jacinto, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|January 26, 2026
Mucosal Melanoma: Treatment Strategies for a Heterogeneous DiseaseJane Mattei, Marcio F Chedid
International Surgery|December 7, 2007
Mirizzi syndrome in a patient with anomalous connection of the cystic duct into the right hepatic ductMarcio F Chedid, Aljamir D Chedid
Melanoma Research|August 31, 2023
Mucosal melanoma: from molecular landscape to current treatment strategiesJane Mattei, Eduardo N Trindade, Marcio F Chedid
Annals of Hepatology|January 3, 2019
ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver TransplantationMarcio F Chedid, Rafael V Picon, Aljamir D Chedid
Nature Reviews. Nephrology|October 3, 2012
The role of complement in antibody-mediated rejection in kidney transplantationMark D Stegall, Marcio F Chedid, Lynn D Cornell
Current Pharmaceutical Design|March 16, 2026
Treatment Strategies for Hepatocellular Carcinoma: When Less is Not MoreGabriel Lazzarotto-da-Silva, Fabiane A Marek, Marcio F Chedid
Current Pharmaceutical Design|March 20, 2025
Surgical Excision Margins in Skin Melanomas with Breslow Thickness Greater than 2 Mm: A Systematic Review and Meta-AnalysisLucas S Floriano, Rafael V Picon, Camila Dagostim, et al.
Current Pharmaceutical Design|June 11, 2020
Immunosuppression in Liver Transplantation: State of the Art and Future PerspectivesGeir I Nedredal, Rafael V Picon, Marcio F Chedid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 29, 2014
Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donorsMarcio F Chedid, Charles B Rosen, Scott L Nyberg, et al.
Arquivos De Gastroenterologia|September 16, 2020
MELD EXCEPTION POINTS PROVIDE AN ENOURMOUS ADVANTAGE FOR RECEIVING A LIVER TRANSPLANT IN BRAZILSoraia Arruda, Marcio F Chedid, Michelle Moraes Jacinto, et al.
Pageof 5